The $17 Stock You’ll Wish You Bought (Last Big Wealth Opportunity of the Decade)
509 segments
Every 10 bagger that Hugh and I have
ever studied, think Tesla, Netflix,
Nvidia, Amazon, they all did this exact
same thing before they exploded, just
like Hugh is about to. And right now,
there is one stock that is doing the
exact same thing that almost nobody is
talking about. By the end of this video,
you'll understand the one pattern. Every
10X stock shares before it moves. And
this specific company, I believe, has a
legitimate shot at being the firm
monster of the year, a 10x stock by
2030. If you're wondering who I am, that
was Hugh, who does our research. My name
is Felix Pinmanx investment banker. I'm
also the founder of the goat academy
where my retired Wall Street mentors
have been teaching regular investors the
institutional strategies for the last
six years. because we've taught well
over 20,000 people so far and I'm not
going to lie to you. This video is going
to be a little bit information dense. So
to make sure it really lands for you,
you get the value out of it that I want
you to get, I'm going to give you a
bonus full research report on everything
that I'm covering today plus more
because videos have a time limit and and
Hugh of course wrote it. So you can
download it for free at
felixfriends.orgpt orpt
and ADPT is the stock ticker we're
talking about here. So, if you're one of
those people who comes for a stock tip
and then complains about it three months
later, now you have the ticker. If
you're the kind of person who wants to
learn how to fish rather than get a
three-day old slightly smelly fish,
stick around. Now, before we dive into
the 10X pick, I need to show you
something that might change how you
think about your portfolio. Because most
people watching this have their
retirement savings in an index fund,
right? The S&P 500. I know you own some
index funds of the S&P 500. Even if you
think you don't, well, you probably do
in your 401k or whatever retirement fund
you have. And it's nice and safe, right?
Sort of set it and forget it, right?
Well, what if I told you that that safe
fund is hiding a secret that could cost
you a fortune? Your S&P 500 index fund
is cheating on you. It has a mistress
because you see it's 500 companies right
which sounds kind of diversified
but right now just 10 stocks just 10
stocks are responsible for 72% of all
your gains. Maybe you don't believe me
or not. I'll show you
the actual chart here in the Winston app
because I just added it to the Winston
app so you can see the stuff and track
it. We'll update this for you every
week. Now, it actually just jumped from
72% to 59% today. And that is because
we're selling off the winners. The
handful of tech giants basically they're
wearing a trench coat pretending to be a
diversified fund. So, if you think you
own the US economy, you actually own a
tech bet on 10 companies. And what
happens when the tech stocks have a bad
week or quarter? while your diversified
retirement fund drops massively because
it was never really diversified at all.
And literally this number yesterday was
72%. Right now it's only 59. And it gets
worse. Those very tech stocks are about
to dilute the heck out of you. Alphabet,
the company that owns Google, just
announced they're printing $80 billion
worth of new stock. And yeah, you can do
that when you're listed company. $80
billion. Meta, Facebook's parent, is
planning something very similar. Now,
what happens when a company prints new
shares? Think of it like a pizza. You
and your friends order the pizza and you
you own two slices of that pizza. Life's
good. You got two slices. Then the
restaurant comes back and says,
"Actually, we cut the pizza into twice
as many slices." You still have two
slices, but the pizza is the same size.
So, your slices just got thinner. Same
pizza, less for you. And that's exactly
what's happening to your index fund
right now. I call it the pizza
treatment. The biggest companies in the
world are printing new slices, and your
slices are getting thinner and thinner
and thinner, which is fine if you're on
a Zenic. Otherwise, you're like, "Where
the heck's my pizza?" You didn't ask for
it. You didn't choose it, but you're
paying the same price for it. And one of
the most legendary investors out there,
best friend of Charlie Manga all his
life, just warned of the S&P right now
is twice as expensive as it is on
average. Warned that it is more
expensive than it was in 2000.
And I don't have to tell you what
happens after 2000. So the
unpopular truth is you're sitting there
holding what you think is a safe,
boring, buy and hold forever kind of an
index fund, but really it is a
concentrated bet on these 10 tech
companies at double the normal
valuation. And those companies are
actively printing shares and making
yours worth less and you have no say in
it. But some people will get very
wealthy over the next years. They'll see
the rotation. and they'll see the money
moving and they'll position themselves
ahead of all the others. And the rest,
well, the rest will find out in 10 years
that their safe fund barely kept up with
inflation and that the money they
thought was growing was quietly being
eaten alive and by then it'll be too
late. Wall Street already knows this.
The big institutions already are
repositioning. The question is, do you
have that plan? And I appreciate that's
going to sound unsettling for many of
you. And that's exactly why I'm running
a seminar for beginner investors for the
first time ever this weekend live from
France. It is called the index fund
trap. Vis S&P 500 is lying to you like a
mistress. And I want to be real with you
in all seriousness. First time I've ever
done this. First time I've ever run the
seminar. I've never taught this material
life before. And honestly, I might never
do it again because it's a it's a lay of
work. So, I'm doing this because of
what's happening right now on the
market. I think it demands it. And what
I'm going to show you is the specific
playbook, the concentration trap, the
dilution, the rotation that's already
happening and exactly how to react to
it, how to position yourself so you're
on the right side of it. And if you
don't learn this now, I think you're
going to find out the hard way in, you
know, five years, 10 years when your
retirement account tells the story. And
by then, you might be like, "Oh, I wish
I would have shown up that Saturday. Um,
it's free, one time only. There'll be no
replay. Don't ask me for one." So, if
you've got a single dollar in an index
fund, you need to be there. Get your
free seat at indexp.com.
Anybody else you know, you should also
be there, send them that link,
indexp.com.
The more people we reach, the bigger the
impact we can make here in a positive
way. But there is good news. You don't
have to sit in a concentrated overpriced
index fund and hope for the best. There
is a way to find the stocks that might
outperform before they move before the
crowd catches on. And it starts with one
pattern that every massive winner in the
stock market history has in common. So
let me show you that. Now, of course,
this isn't financial advice. I'm not a
registered financial adviser. not
telling you to buy the stock. Couldn't
care less whether you do. I'm teaching
you the principle. I'm teaching you the
rules. I'm teaching you how to fish. I'm
not handing you a fish that's going to
go smelly and rotten in three days if
the cats don't eat it. You don't let
leave food out with Hugh around. I can
tell you that much. The one thing every
10 ber has in common. What do you think
that is? Put it in the comments down
below. Seriously, put in the comments
down below. Just pause for a second. Put
in the comments down below. Don't cheat.
What do Tesla, Netflix, and Apple, and
all these great companies have in common
besides making people very, very rich
before any of them exploded? They all
did something that scared everybody
away. Did what? The stock chart did this
for a very, very, very long time. It
went sideways for years. I'm talking
literally, we've done the research, two
to four years. Dr. sat there doing nada,
flatlining like a heart monitor. And
during those boring, painful years, most
people gave up on the stock. They sold,
they moved on. They said, "This stock is
dead." And then
bingo. Why does it work? Think of it
like a spring. Imagine you're pushing a
spring down onto a table. You push it
down for a month, it'll bounce back a
little. You push it down for a year
really, really, really hard, it'll
bounce back more. you push it down for
four years, when you finally let go,
that thing flies to the ceiling. And
that's what's happening when a stock
goes sideways for years. The spring is
being compressed. The business is
growing underneath. More customers, more
revenue, more profit, but the stock
price isn't reflecting any. And at some
point, the market has to catch up. And
when it does, it's your 10x
possibility. Let me show you a real
example here. Tesla between 2017
somewhere here and 2020 it basically
traded like a boring little thing just
going sideways right absolutely bugger
all happening there on that stock trap
just doing nothing absolutely nothing
and the headlines were like Tesla's
going bankrupt Elon is crazy this
company is done but underneath it they
were building gigafactories they were
ramping up Model 3 production they were
growing revenue and then In 2020, the
spring released and the stock went up 10
10x 17x whatever. If you look at you
look at Netflix in 2011, Netflix crashed
80%. Everybody said streaming is a fad.
And then nothing happened 2012. Nothing
at all. Nothing at all. Nothing at all.
2013 came around and boom, this thing
has been going up and up and up and up
and up and up and up and up, you know,
way way way past the 10x because they
were adding 2 million streaming
subscribers every quarter. And look at
Apple 2015 to 2018, basically nothing
happened at all. Four years, Apple stock
traded basically the same price and
people thought Apple has done grown, but
the iPhone and store base was exploding.
service revenue was compounding and the
company was buying back billions of his
own shares that stock to
really really really start going up 90%
that year alone and it doubled again and
again. So what do we look for? Here's
the three-step checklist. I find a stock
that's been going sideways for a very
long time and here's the stock chart of
ADPT. It's trading at 2022 valuations.
It's done nothing in 2022, nothing in
2023, nothing in 2024, nothing in 2025.
I asked some questions. Is the business
growing while the stock is flat? Are
institutions quietly accumulating? And
is there a catalyst approaching? I'm
looking for a disconnect. I'm looking
for volume to slowly increase down here.
Nothing major, just a slow increase. So,
I can see the smart money on the green
days is buying. And on the big red days,
the guys who wanted to get out of this
are finally out of this. until finally
these red candles get smaller. Write
these down if you haven't already. And
there is a stock doing this right now in
my humble opinion. Don't run out and buy
it. You got to come to your own
conclusion. And it's a stock that could
literally save your life. Like ADPT, a
company called Adaptive Biotech
Technologies. Now, I've got it open here
in in the Winston app. It's got a
terrible score, right? Terrible score.
We score at 100. See, the score is
improving a little, but not a lot over
the last year or so. But it's growing,
right? It's actually growing quite
impressively. And what it's all about is
this. And by the way, if you want to
play around with the Winston app, we
literally are giving it away. There's a
whole free month trial to it. So for a
whole month, you're going to get access
to it for free. Um, if you don't like
it, just cancel on day 29. Links down
below in the description. But in all
seriousness, every 3 minutes in America,
someone's diagnosed with blood cancer,
leukemia, lymphoma, all that stuff. And
they're literally 1.7 million Americans
right now living with or in remission
from a blood cancer. Now imagine you're
one of those people. You've just gone
through months of chemotherapy. Your
hair fell out. You couldn't eat. You
could barely get out of bed. And finally
your doctor looks at you and says the
treatments worked. You think we got it
though. You think or you know. That's
literally the scariest question in
medicine, right? Because even a tiny
amount of cancer, if it's still hiding
in your body, invisible to a normal
blood test, invisible to a scan, it can
come back. And that is where this
company comes in. And by the way, there
is never any sponsorship on this
channel, right? I never take any money
from this any any company ever, never
will, no endorsements of any kind. I
also don't own the stock. So, I just
want to be very clear with that. I might
own the stock at some point in the
future. I might buy it and I might sell
it and I might not tell you about it
because I don't make a video every
single day on every stock I buy. But
what this company does in a simple way
is they make a test called clonosq.
And what it does is every cancer has
sort of a unique fingerprint. Think of
it like a barcode like the barcode on a
product at a grocery store, right? They
read your blood and they look for that
specific barcode. And it is so sensitive
it can find one single cancer cell
hiding among 1 million healthy cells.
One in a finding one specific person in
the entire city of I Dallas or something
by their fingerprint alone. So it's like
a smoke detector for cancer. And a
regular checkup is like walking through
your house looking for I don't know
flames, right? teeny tiny flames. If you
see fire, it's bad. So, Cloner SQ is the
smoke detector before the fire starts.
It catches the wisp of smoke before
there is ever a fire, before the cancer
comes back, before it spreads. And that
early warning changes everything. Your
doctor can adjust your treatment before
it returns instead of waiting until it's
too late. And
what makes this interesting as an
investment thesis and this of course is
a high-risk investment thesis like all
investments but biotech particularly is
Bono SEQ is the only test of its kind
that's been cleared by the FDA. Nobody
else has it. There over 250 medical
studies that back it up. More than half
of all blood cancer doctors in America
already use it. And there are over 160
drug companies that are using it in
their clinical trials to test whether
their new cancer drugs actually work.
insurance covers it for over 300 million
Americans. So most patients can get it
without paying for it. But the punchline
is this. They're stood at less than 15%
penetration in most of the cancers it
treats. Think about that. The only FDA
clear test, half of doctors are already
on board. Insurance companies cover it
and 85% of the opportunity is still
ahead of remember our framework. Stone
one is the business growing while the
stock is flat. Well, going to the
Winston app, revenue growth, right? It's
been growing
pretty impressively. 35% last quarter,
51% the quarter before, 102% the quarter
before that, and it's been growing for
like four years straight. That's the
spring compression we saw in Tesla and
in Netflix and so on. And they're
forecasting about 270 million in
revenue. Total market is about 6
billion. So they're doing about 5%
of the total addressable pi. So what's
the catalyst? Something that forces the
market to look at this and go, "This is
actually worth more than it is trading
at, right?" Well, this year, for the
first time ever, this company is
expected to become profitable. They've
never made money before. Like most of
these biotech companies don't make money
for years. Now they probably will. And
when a company flips from losing money
to making money, the market tends to
wake up for it. It's like the switch
gets flipped, right? The stock goes from
being ignored to being well, it's on
every screen because a lot of investors,
a lot of pension funds, they want to
invest in profitable companies. It's
easier to justify. It's easier to
understand. So, let me tell you why the
10X in my humble opinion isn't a
fantasy. Doesn't mean it's going to
happen. I haven't got a crystal ball.
Doesn't mean there isn't high risk and
you're losing your money. So, position
size accordingly and obviously decide
for your own whether this is something
you want to be exposed to. Definitely
not the sort of thing you want to put
all your money into. The whole company
right now it's worth about 2.7 billion
here market cap, right? I've got it on
the slide here too, but it's 2.7
billion. The total market they can go
after is six billion. So if they capture
say a quarter of that, I'm not saying
they're going to get everything. Say
they get a billion and a half in revenue
and at the moment they're the only FDA
cleared player. So why wouldn't they get
fast growth, you get very good margins,
you get a moat, there should be a
premium for the way this is valued,
right? Now should's always a dangerous
word. We've had a 4year base. It peaked
in 2021. It crashed really, really,
really hard. Let me show you the chart
here. Also give you a little bit of an
idea of just how risky biotech investing
really is if you haven't got rules. This
thing from the very top is down 87%
right now. This is not something you buy
and hold till the end of time. No. But
since 2022, we've done nothing. So if we
were to go back up to where we once
were, and again I'm not promising you
that that in itself would be, you know,
why were they trading that high? It was
during the pandemic. You know, lots of
testing going on there. So there is
risk, right? It is a small company.
There is therefore more risk. There is
competition. There's a company called
Natira. We're expanding into blood
cancers. There'll be competition. There
always is. and they have to execute.
Nothing is guaranteed. Management might
lose their marbles. So, this is not a
buy recommendation. You got to do your
own homework. But it's the sort of thing
that I look at and I go, that's very
interesting. But it's only interesting
when you understand the framework, you
understand the base, you understand the
revenue growth, you understand the
catalyst. So, to me, I love stocks that
do nothing for years. I don't want to
own them where they do nothing for
years. But when they start breaking out
of that, that's when I'm interested to
actually own them. And most importantly,
the message I want to get across to you
is that if you're still an index fund
investor and you don't have a plan for
what's coming, join me live this
weekend, first time I've ever taught
this publicly, I might never do it
again. It's free. It's live. So, if
you're relying on the S&P 500 for your
retirement, this is the most important
two hours you're going to spend this
year. Go to index.com, grab yourself a
free seat before it fills up. Show up on
time. There'll be no replay. And I'll
see you there. Share it with people who
might benefit from this, too. And if
this been helpful for you, share the
video, share the link to index.com with
people who might benefit from it. And I
wish you tremendous success. 350
billion. That is how much fresh cash
Wall Street needs to come up with in the
next few weeks just to absorb three
massive IPOs.
Ask follow-up questions or revisit key timestamps.
This video, presented by investment expert Felix Pinmanx, argues that the S&P 500 is currently dangerously concentrated in a few tech stocks and is suffering from share dilution, which could negatively impact long-term retirees. He introduces a strategy for identifying potential 10x stock opportunities by looking for companies that have shown strong underlying growth while their stock prices have remained flat for years. Pinmanx illustrates this with the example of Adaptive Biotechnologies (ADPT), a company developing a cancer detection test, noting its consistent growth and potential profitability as a catalyst for a future breakout.
Videos recently processed by our community